€ 37.50 · 4.5 (368) · Auf Lager
Call comments on phase III Sutent results - The Life Raft Group
Introduction: Biomedical Innovation and Policy in the Twenty-First Century
Survival of gastrointestinal stromal tumor patients in the imatinib era: life raft group observational registry, BMC Cancer
Michelle Durborow, Author at The Life Raft Group
PPT - Gleevec® (imatinib mesylate) PowerPoint Presentation, free download - ID:1359549
Survival in advanced GIST has improved over time and correlates with increased access to post-imatinib tyrosine kinase inhibitors: results from Life Raft Group Registry, Clinical Sarcoma Research
Imatinib use for gastrointestinal stromal tumors among older patients in Japan and Taiwan
Imatinib - an overview
PPT - Gleevec® (imatinib mesylate) PowerPoint Presentation, free download - ID:1359549
Novartis Archives - The Life Raft Group
The State of GIST Treatments - The Life Raft Group